drugset / Trial / NCT02187809
Safety and Tolerability of Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome
NaSingle-groupOpen-labelTreatment
Summary
To investigate the long-term safety and tolerability of clobazam when administered for 1 year as adjunctive therapy in paediatric patients aged ≥1 to ≤16 years with Dravet Syndrome.
Timeline
- Start
- 2015-03
- Primary completion
- 2015-10
- Completion
- 2015-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clobazam | Small molecule | 2 mg/kg | Oral |
| Subject | Clobazam | Small molecule | 80 mg | Oral |